Metraipolis › archive › dc_ca395a77e4bf

Development of a novel prognostic score for 1-year survival in immunotherapy-treated patients with unresectable HCC: the ALIVE-IO score — Europe PMC PMID:40948746

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40948746
DOI
10.3389/fimmu.2025.1648248
License (as archived)
solo-consultazione
Archived
2026-11-10T06:22:35.128Z
SHA-256 of the archived text
56574cbab936ac43962ed3eedde039e9ddd24bce09a4b87f4f80f5ecb6bf7c21
Stable URL of this page
https://metraipolis.com/documento/dc_ca395a77e4bf

How to cite

Development of a novel prognostic score for 1-year survival in immunotherapy-treated patients with unresectable HCC: the ALIVE-IO score — Europe PMC PMID:40948746 — Europe PMC (en), https://europepmc.org/article/MED/40948746 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca395a77e4bf (Metraipolis archive dc_ca395a77e4bf, sha256 56574cbab936ac43962ed3eedde039e9ddd24bce09a4b87f4f80f5ecb6bf7c21)
BibTeX
@misc{dcca395a77e4bf,
  title = {Development of a novel prognostic score for 1-year survival in immunotherapy-treated patients with unresectable HCC: the ALIVE-IO score — Europe PMC PMID:40948746},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40948746},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca395a77e4bf; sha256 56574cbab936ac43962ed3eedde039e9ddd24bce09a4b87f4f80f5ecb6bf7c21},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40948746. Agents can read the archived copy with the MCP tool read_document.